Clinical recognition and management of patients exposed to biological warfare agents.

[1]  M. Queipo-Ortuño,et al.  Posttreatment Follow-Up of Brucellosis by PCR Assay , 1999, Journal of Clinical Microbiology.

[2]  C. Peters,et al.  Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. , 1999, Vaccine.

[3]  Robert W Pinner,et al.  Bioterrorism alleging use of anthrax and interim guidelines for management--United States, 1998. , 1999, MMWR. Morbidity and mortality weekly report.

[4]  G. Araj,et al.  Human brucellosis: a classical infectious disease with persistent diagnostic challenges. , 1999, Clinical laboratory science : journal of the American Society for Medical Technology.

[5]  T. O'Toole,et al.  Smallpox: An attack scenario. , 1999, Emerging infectious diseases.

[6]  J. Tucker,et al.  Historical trends related to bioterrorism: An empirical analysis. , 1999, Emerging infectious diseases.

[7]  S. Leppla,et al.  Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen. , 1999, Vaccine.

[8]  P. Formenty,et al.  Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation. , 1999, The Journal of infectious diseases.

[9]  Jonathan Y. Richmond,et al.  Biosafety in microbiological and biomedical laboratories , 1999 .

[10]  T. Krakauer,et al.  Immune response to staphylococcal superantigens , 1999, Immunologic research.

[11]  D. Franz,et al.  STAPHYLOCOCCAL ENTEROTOXIN B AND RELATED PYROGENIC TOXINS , 1999 .

[12]  J. Smith,et al.  Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. , 1998, Virology.

[13]  M. A. Olson,et al.  Development of engineered vaccines effective against structurally related bacterial superantigens. , 1998, Vaccine.

[14]  S. Welkos,et al.  Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. , 1998, Vaccine.

[15]  J. Ezzell,et al.  Antibiotic Treatment of Experimental Pneumonic Plague in Mice , 1998, Antimicrobial Agents and Chemotherapy.

[16]  W. Tunnicliffe,et al.  Post-infection fatigue syndrome following Q fever. , 1998, QJM : monthly journal of the Association of Physicians.

[17]  A. Pomerantsev,et al.  Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infection. , 1997, Vaccine.

[18]  P. Ocón,et al.  Rapid diagnosis of human brucellosis by peripheral-blood PCR assay , 1997, Journal of clinical microbiology.

[19]  K. Jahans,et al.  The characterisation of Brucella strains isolated from marine mammals. , 1997, Veterinary microbiology.

[20]  Scott Thaler,et al.  Clinical and neuroradiographic manifestations of eastern equine encephalitis. , 1997, The New England journal of medicine.

[21]  H. Yang,et al.  Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice , 1997, Antimicrobial agents and chemotherapy.

[22]  P. Jahrling,et al.  The potential of 5′ nuclease PCR for detecting a single-base polymorphism inOrthopoxvirus , 1997, Molecular and cellular probes.

[23]  T. Ksiazek,et al.  Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  David R Franz,et al.  Medical Aspects of Chemical and Biological Warfare , 1997 .

[25]  J. D. Colmenero,et al.  Complications Associated with Brucella melitensis Infection: A Study of 530 Cases , 1996, Medicine.

[26]  C. Wilhelmsen,et al.  Lesions of Acute Inhaled Lethal Ricin Intoxication in Rhesus Monkeys 1 2 , 1996, Veterinary pathology.

[27]  P. Jahrling,et al.  Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. , 1996, Archives of virology. Supplementum.

[28]  T. Marrie.  Coxiella burnetii (Q fever) pneumonia. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  A D Coox,et al.  Factories of death. , 1995, Science.

[30]  E. J. Young,et al.  An overview of human brucellosis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  M. Hugh-jones,et al.  The Sverdlovsk anthrax outbreak of 1979. , 1994, Science.

[32]  C. Peters,et al.  Hantaviruses and hantavirus pulmonary syndrome. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  B. Marmion,et al.  Vaccine prophylaxis of Q fever: A follow‐up study of the efficacy of Q‐Vax (CSL) 1985‐1990 , 1994, The Medical journal of Australia.

[34]  J. Williams,et al.  Evaluation of specificity of indirect enzyme-linked immunosorbent assay for diagnosis of human Q fever , 1994, Journal of clinical microbiology.

[35]  R. Rico-Hesse,et al.  New arenavirus isolated in Brazil , 1994, The Lancet.

[36]  K. Watanabe,et al.  [Inhalation anthrax]. , 1994, Ryoikibetsu shokogun shirizu.

[37]  J. Maiztegui,et al.  Antiviral treatment of Argentine hemorrhagic fever. , 1994, Antiviral research.

[38]  S. Bavari,et al.  Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release , 1993, Infection and immunity.

[39]  D. Smith,et al.  A large Q fever outbreak in the West Midlands: clinical aspects. , 1993, Respiratory medicine.

[40]  D. Raoult,et al.  Treatment of Q fever , 1993, Antimicrobial Agents and Chemotherapy.

[41]  J. Ezzell,et al.  Postexposure prophylaxis against experimental inhalation anthrax. , 1993, The Journal of infectious diseases.

[42]  R. Hardiman,et al.  Endocarditis Caused by Brucella Melitensis , 1993, The Medical journal of Australia.

[43]  M. Dolan,et al.  Q fever meningoencephalitis in a soldier returning from the Persian Gulf War. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  D H Walker,et al.  Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Hanes,et al.  Efficacy of Prophylactic and Therapeutic Administration of Antitoxin for Inhalation Botulism , 1993 .

[46]  J. Middlebrook.  Contributions of the U.S. Army to Botulinum Toxin Research , 1993 .

[47]  F. Grimont,et al.  Molecular typing of Brucella with cloned DNA probes. , 1992, Research in microbiology.

[48]  W. Foege.  Preventive medicine and public health. , 1992, JAMA.

[49]  D. Smith,et al.  The chest X ray in Q-fever: a report on 69 cases from the 1989 West Midlands outbreak. , 1991, The British journal of radiology.

[50]  R. Rico-Hesse,et al.  Venezuelan haemorrhagic fever , 1991, The Lancet.

[51]  R. Johnston,et al.  Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. , 1991, Virology.

[52]  E. J. Young,et al.  Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. , 1991, Reviews of infectious diseases.

[53]  A. Fernández-Nebro,et al.  Osteoarticular complications of brucellosis. , 1991, Annals of the rheumatic diseases.

[54]  A. Izzo,et al.  Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs , 1990, Epidemiology and Infection.

[55]  J. Ezzell,et al.  Identification of Bacillus anthracis by using monoclonal antibody to cell wall galactose-N-acetylglucosamine polysaccharide , 1990, Journal of clinical microbiology.

[56]  V. Kostić,et al.  The course of infection with Coxiella burnetii. , 1990 .

[57]  R. Cook,et al.  Class II MHC molecules are specific receptors for staphylococcus enterotoxin A. , 1989, Science.

[58]  P. Marrack,et al.  V beta-specific stimulation of human T cells by staphylococcal toxins. , 1989, Science.

[59]  J. Fraser.  High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR , 1989, Nature.

[60]  J. Huggins.  Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. , 1989, Reviews of infectious diseases.

[61]  A. Shepherd,et al.  Antibody response in Crimean-Congo hemorrhagic fever. , 1989, Reviews of infectious diseases.

[62]  H. W. Lee,et al.  Hemorrhagic fever with renal syndrome in Korea. , 1989, Reviews of infectious diseases.

[63]  M. Drayson,et al.  The toxicity, distribution and excretion of ricin holotoxin in rats. , 1989, Toxicology.

[64]  T. Marrie,et al.  Truckin' pneumonia—an outbreak of Q fever in a truck repair plant probably due to aerosols from clothing contaminated by contact with newborn kittens , 1989, Epidemiology and Infection.

[65]  L. Simpson.  CHAPTER 7 – Peripheral Actions of the Botulinum Toxins , 1989 .

[66]  J. D. Colmenero Castillo,et al.  Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis. , 1989, Chemotherapy.

[67]  S. Shetty,et al.  Genito-urinary complications of brucellosis. , 1988, British journal of urology.

[68]  G. Alarcón,et al.  Articular involvement in human brucellosis. , 1988, The Journal of rheumatology.

[69]  A. Mousa,et al.  The nature of human brucellosis in Kuwait: study of 379 cases. , 1988, Reviews of infectious diseases.

[70]  Management of patients with suspected viral hemorrhagic fever. , 1988, MMWR supplements.

[71]  F. Fenner.  Smallpox and its eradication , 1988 .

[72]  G Dupuis,et al.  An important outbreak of human Q fever in a Swiss Alpine valley. , 1987, International journal of epidemiology.

[73]  Huxsoll Dl,et al.  Veterinary services in biological disasters. , 1987 .

[74]  E. S. Smith,et al.  A prospective study of the epidemiology and ecology of Lassa fever. , 1987, The Journal of infectious diseases.

[75]  J. Canela-Soler,et al.  An outbreak of Brucella melitensis infection by airborne transmission among laboratory workers. , 1987, American journal of public health.

[76]  W. C. Patrick,et al.  Veterinary services in biological disasters. , 1987, Journal of the American Veterinary Medical Association.

[77]  M. Brummer‐Korvenkontio,et al.  Complex-specific immunoglobulin M antibody patterns in humans infected with alphaviruses , 1986, Journal of clinical microbiology.

[78]  E. Gotuzzo,et al.  An Evaluation of Diagnostic Methods for Brucellosis , 1986 .

[79]  J. McCormick,et al.  Lassa fever. Effective therapy with ribavirin. , 1986, The New England journal of medicine.

[80]  E. Gotuzzo,et al.  An evaluation of diagnostic methods for brucellosis--the value of bone marrow culture. , 1986, The Journal of infectious diseases.

[81]  J. Forsyth.  Joint FAO/WHO expert committee on brucellosis. , 1986, World Health Organization technical report series.

[82]  A. Rauber,et al.  Castor bean toxicity re-examined: a new perspective. , 1985, Veterinary and human toxicology.

[83]  J. Joubert,et al.  A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part II. Management of patients. , 1985, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[84]  A. Shepherd,et al.  A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part V. Virological and serological observations. , 1985, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[85]  W Schaffner,et al.  Tularemia: A 30‐Year Experience With 88 Cases , 1985, Medicine.

[86]  J. Roehrig,et al.  Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus. , 1985, Virology.

[87]  P. Jahrling,et al.  Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization. , 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[88]  E. Edlinger.  Chronic Q fever. , 1987, The Journal of infection.

[89]  B. Feery,et al.  VACCINE PROPHYLAXIS OF ABATTOIR-ASSOCIATED Q FEVER , 1984, The Lancet.

[90]  E. Gotuzzo,et al.  Hematologic changes in brucellosis. , 1984, The Journal of infectious diseases.

[91]  S. Aamdal,et al.  Phase I study of the plant protein ricin. , 1984, Cancer research.

[92]  M. Kende,et al.  In-vivo activity of antivirals against exotic RNA viral infections. , 1984, The Journal of antimicrobial chemotherapy.

[93]  W. Emmett Barkley,et al.  Biosafety in microbiological and biomedical laboratories , 1984 .

[94]  T. Butler.  Plague and Other Yersinia Infections , 1983, Current Topics in Infectious Disease.

[95]  J. Roehrig,et al.  Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies. , 1982, Journal of immunology.

[96]  G. Alarcón,et al.  Articular involvement in human brucellosis: a retrospective analysis of 304 cases. , 1982, Seminars in arthritis and rheumatism.

[97]  A. D. Evans,et al.  Q FEVER IN AN URBAN AREA , 1982, The Lancet.

[98]  D. Gill,et al.  Bacterial toxins: a table of lethal amounts , 1982, Microbiological reviews.

[99]  R Crompton,et al.  Georgi Markov — Death in a Pellet , 1980, The Medico-legal journal.

[100]  I. Arita.  Virological evidence for the success of the smallpox eradication programme , 1979, Nature.

[101]  A. Spicer.  Military Significance of Q Fever: A Review 1 , 1978, Journal of the Royal Society of Medicine.

[102]  N. Karabatsos.  Supplement to International Catalogue of Arboviruses including certain other viruses of vertebrates. , 1978, The American journal of tropical medicine and hygiene.

[103]  Ebola haemorrhagic fever in Zaire, 1976. , 1978, Bulletin of the World Health Organization.

[104]  D. Burke.  Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. , 1977, The Journal of infectious diseases.

[105]  M. B. Matthews,et al.  Chronic Q fever. , 1976, The Quarterly journal of medicine.

[106]  León Ca.  Sequelae of Venezuelan Equine Encephalitis in Humans: A Four Year Follow-up , 1975 .

[107]  C. Leon,et al.  Sequelae of Venezuelan equine encephalitis in humans: a four year follow-up. , 1975, International journal of epidemiology.

[108]  M. K. Mukherjee,et al.  Virus content of smallpox scabs. , 1974, Bulletin of the World Health Organization.

[109]  E. Derrick.  The course of infection with Coxiella burneti. , 1973, The Medical journal of Australia.

[110]  M. K. Mukherjee,et al.  Virus excretion in smallpox. 1. Excretion in the throat, urine, and conjunctiva of patients. , 1973, Bulletin of the World Health Organization.

[111]  W. D. Sudia,et al.  An epidemiologic study of Venezuelan equine encephalomyelitis in Costa Rica, 1970. , 1972, American journal of epidemiology.

[112]  Murnane Tg.  [Venezuelan equine encephalitis]. , 1989, Bulletin - Office international des epizooties.

[113]  G. Martini.  Marburg virus disease , 1973, Springer Berlin Heidelberg.

[114]  B. Henderson,et al.  Venezuelan equine encephalomyelitis: surveys of human illness during an epizootic in Guatemala and El Salvador. , 1971, American journal of epidemiology.

[115]  K. Johnson,et al.  An outbreak of Venezuelan encephalitis in man in the Panamá Canal Zone. , 1970, The American journal of tropical medicine and hygiene.

[116]  P F Wehrle,et al.  An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe. , 1970, Bulletin of the World Health Organization.

[117]  A. Read.  Health aspects of chemical and biological weapons: Report of a WHO group of consultants , 1970 .

[118]  John Cookson,et al.  A survey of chemical and biological warfare , 1969 .

[119]  J. N. Welsh,et al.  The 1959 outbreak of Eastern encephalitis in New Jersey. 5. The inapparent infection:disease ratio. , 1968, American journal of epidemiology.

[120]  J. N. Welsh,et al.  The 1959 outbreak of Eastern encephalitis in New Jersey. 6. The frequency of prior infection. , 1968, American journal of epidemiology.

[121]  R. Al.  Rural epidemic encephalitis in Venezuela caused by a group A arbovirus (VEE). , 1967 .

[122]  A. L. Rossi.  Rural epidemic encephalitis in Venezuela caused by a group A arbovirus (VEE). , 1967, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

[123]  A. Hogge,et al.  Antibiotic prophylaxis and therapy of airborne tularemia. , 1966, Bacteriological reviews.

[124]  A. Rao,et al.  Assessment of an isothiazole thiosemicarbazone in the prophylaxis of contacts of variola major. , 1966, Lancet.

[125]  A. Benenson.  CONTROL OF COMMUNICABLE DISEASES IN MAN , 1966 .

[126]  L. Proença,et al.  Methisazone in prevention of variola minor among contacts. , 1965, Lancet.

[127]  A. Shelokov,et al.  Virus Isolations from Human Cases of Hemorrhagic Fever in Bolivia , 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[128]  Easterday Bc.  Rift valley fever. , 1965, Advances in veterinary science.

[129]  A. Downie,et al.  The recovery of smallpox virus from patients and their environment in a smallpox hospital. , 1965, Bulletin of the World Health Organization.

[130]  D. Lackman,et al.  RECURRENT REACTION OF SITE OF Q FEVER VACCINATION IN A SENSITIZED PERSON. , 1964, Military medicine.

[131]  K. Hart,et al.  AN OUTBREAK OF EASTERN EQUINE ENCEPHALOMYELITIS IN JAMAICA, WEST INDIES. I. DESCRIPTION OF HUMAN CASES. , 1964, The American journal of tropical medicine and hygiene.

[132]  D. J. Bauer,et al.  PROPHYLACTIC TREATMENT OF SMALL POX CONTACTS WITH N-METHYLISATIN BETA-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN). , 1963, Lancet.

[133]  R. Mckinney,et al.  USE OF AN ATTENUATED STRAIN OF VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS FOR IMMUNIZATION IN MAN. , 1963, The American journal of tropical medicine and hygiene.

[134]  D. Lackman,et al.  Intradermal sensitivity testing in man with a purified vaccine for Q fever. , 1962, American journal of public health and the nation's health.

[135]  G. Harper,et al.  Airborne micro-organisms: survival tests with four viruses , 1961, Epidemiology and Infection.

[136]  F. McCrumb,et al.  AEROSOL INFECTION OF MAN WITH PASTEURELLA TULARENSIS. , 1961, Bacteriological reviews.

[137]  W. Wheeler,et al.  Control of Communicable Diseases in Man. , 1961 .

[138]  G. Meiklejohn,et al.  Studies on the virus content of mouth washings in the acute phase of smallpox. , 1961, Bulletin of the World Health Organization.

[139]  G. Meiklejohn,et al.  Air sampling to recover variola virus in the environment of a smallpox hospital. , 1961, Bulletin of the World Health Organization.

[140]  D. Clarke,et al.  Two nonfatal human infections with the virus of eastern encephalitis. , 1961, The American journal of tropical medicine and hygiene.

[141]  T. M. Peery,et al.  Brucellosis and heart disease. II. Fatal brucellosis: a review of the literature and report of new cases. , 1960, The American journal of pathology.

[142]  S. Kato,et al.  A Study on the Morphological and Cyto-Immunological Relationship between the Inclusions of Variola, Cowpox, Rabbitpox, Vaccinia (Variola Origin) and Vaccinia IHD and a Consideration of the Term " Cuarnieri Body ". , 1959 .

[143]  R. Feemster.  Equine encephalitis in Massachusetts. , 1957, The New England journal of medicine.

[144]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[145]  F. Maccallum,et al.  Survival of variola virus in raw cotton. , 1957, Bulletin of the World Health Organization.

[146]  Benenson As,et al.  Studies on Q fever in man. , 1956 .

[147]  A. Benenson,et al.  Studies on Q fever in man. , 1956, Transactions of the Association of American Physicians.

[148]  J. Robic,et al.  Chloramphenicol and terramycin in the treatment of pneumonic plague. , 1953, The American journal of medicine.

[149]  A. Langmuir,et al.  Biological warfare defense. 2. The Epidemic Intelligence Service of the Communicable Disease Center. , 1952, American journal of public health and the nation's health.

[150]  T. H. Tieh,et al.  Primary pneumonic plague in Mukden, 1946, and report of 39 cases with three recoveries. , 1948, The Journal of infectious diseases.

[151]  H. J. Morgan.  Pleuropulmonary tularemia. , 1947, Annals of internal medicine.

[152]  H. Gold,et al.  EQUINE ENCEPHALOMYELITIS IN A LABORATORY TECHNICIAN WITH RECOVERY , 1942 .

[153]  E. Horgan,et al.  Cross Immunity Experiments in Monkeys Between Variola, Alastrim and Vaccinia , 1939, Epidemiology and Infection.

[154]  R. Wyckoff,et al.  VENEZUELAN EQUINE ENCEPHALOMYELITIS. , 1938, Science.

[155]  R. Hitchcock.  Pre-Aino Race in Japan. , 1892, Science.